Results 131 to 140 of about 165,855 (235)

Resolved Stellar Mass Estimation of Nearby Late-type Galaxies for the SPHEREx Era: Dependence on Stellar Population Synthesis Models

The Astronomical Journal
The upcoming all-sky infrared spectrophotometric SPHEREx mission is set to provide spatially resolved stellar mass maps of nearby galaxies, offering more detailed insights than integrated light observations.
Jeong Hwan Lee, Minjin Kim, Taehyun Kim, Hyunjin Shim, Luis C. Ho, Ho Seong Hwang, Hyunmi Song, Dohyeong Kim, Yujin Yang, Woong-Seob Jeong   +9 more
doaj   +1 more source

Stellar Populations of the Dwarf Galaxy UKS 2323−326 in the Sculptor Group [PDF]

, 1999
Myung Gyoon Lee, Yong‐Ik Byun
openalex   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

On the Origin of Fast-rotating Stars. I. Photometric Calibration and Results of AO-assisted BVRI+Hα Imaging of NGC 330 with SAMI/SOAR

The Astrophysical Journal
H α emission is a clear indicator of circumstellar activity in Be stars, historically employed to assess the classical Be star (CBe) population in young open clusters (YOCs).
Felipe Navarete, Pedro Ticiani dos Santos, Alex Cavaliéri Carciofi, André Luiz Figueiredo   +3 more
doaj   +1 more source

Stellar population synthesis diagnostics [PDF]

, 1998
Y. K. Ng
openalex   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Far‐Ultraviolet Spectra of Starburst Galaxies: Stellar Population and the Kinematics of the Interstellar Medium [PDF]

, 1998
R. M. González Delgado, Claus Leitherer, Timothy M. Heckman, James D. Lowenthal, Henry C. Ferguson, Carmelle Robert   +5 more
openalex   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

Stellar-population samples at the galactic poles. I. Proper-motion stars, blue objects, and eclipsing binaries near the south pole

, 1968
O. J. Eggen
openalex   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source